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Embolic Infarction Associated with Cardiac Amyloidosis
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Embolic cerebral infarction due to cardiac amyloidosis is rare. We report two patients with amyloidosis who 
developed cerebral infarcts. These embolic infarcts were probably related to cardiac involvement of amyloidosis, 
which was based on results of myocardial biopsy (Patient 1), and kidney biopsy and characteristic echocardiographic 
features including granular sparkling, restrictive cardiomyopathy and the presence of mural thrombus (Patient 2). 
Diffuse amyloid infiltration of the heart may have lead to impairment of myocardial function and subsequent mural 
thrombosis.  Cardiomyopathy  due  to  cardiac  amyloidosis  should  be r e c o g n i z e d  a s  o n e  o f  t h e  c a u s e s  o f  
cardioembolic infarction.
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The most common cause of cardioembolic stroke is 
non-valvular atrial fibrillation. Other causes include 
cardiomyopathy, which occasionally produces mural 
thrombosis. Cardiac involvement of amyloidosis is not 
uncommon in systemic amyloidosis associated with 
multiple myeloma, and is one of the causes of 
infiltrative cardiomyopathy in adults.
1 However, cerebral 
embolism in relation to cardiac amyloidosis has rarely 
been reported in the neurology literature. We report two 
patients who had embolic infarcts associated with 
cardiac amyloidosis. The diagnosis was based on the 
biopsy of myocardium (Patient 1) and the kidney biopsy 
and echocardiographic results (Patient 2).
CASE REPORT
Patient 1
A 29-year-old woman with known cardiac 
amyloidosis suddenly developed three episodes of 
transient left hemiparesis. The patient had first been seen 
at our hospital three months earlier because of dyspnea 
on exertion (NYHA class III). Electrocardiogram (ECG) 
revealed sinus rhythm with low voltage QRS and Q 
waves in leads V2-3. Radiographs of the chest showed 
cardiomegaly with bilateral pleural effusion. Trans-
thoracic echocardiography (TTE) showed thickened left 
ventricular (LV) wall with high left ventricular end- 
diastolic pressure (LVEDP) and inferior vena cava (IVC) 
plethora that reflected the high pressure of right atrium 
(ejection fraction=40%). Both atria were enlarged and 
transmitral doppler flow revealed typical restrictive 
pattern. These findings were consistent with restrictive 
cardiomyopathy. Microscopical examination of a 
specimen from endomyocardial biopsy, stained with Cho KH, et al. Embolic Infarction Associated with Cardiac Amyloidosis 
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Figure 3. Kidney biopsy findings of patient 2. (A) Deposition of
amyloid is shown in blood vessels of medulla (arrows) (H&E 
×200). (B) “Apple-green” birefringence under polarized light 
(Congo red stain ×200).
Figure 1. Endomyocardial biopsy findings of patient 1. (A) 
Deposition of amyloid is shown (arrow) (H&E ×200). (B) 
“Apple-green” birefringence under polarized light (Congo red 
stain ×400).
Figure 2. T2-weighted MRI of patient 1 shows cerebral infarcts 
in the right basal ganglia and corona radiata. MRA reveals near
total occlusion or severe stenosis of the right distal M1 and 
proximal M2 portion of the MCA.
Congo red, showed amyloid deposition (Fig. 1). Serum 
and urine protein electrophoresis showed no abnormal 
zone of restriction with monoclonal antibodies. Bone 
marrow, rectum and abdominal fat aspiration biopsies 
showed no abnormality. Nerve conduction studies 
revealed no evidence of neuropathy. Based on these 
findings, a diagnosis of cardiac amyloidosis was made. 
There was no evidence of systemic involvement nor 
family history of amyloidosis. Torasemide, amiloride 
and spironolactone were prescribed and heart 
transplantation was under consideration.
She had no history of hypertension and diabetes. She 
had never smoked and did not drink alcohol. On 
examination, cardiac murmur and cervical bruit were not 
heard. ECG showed sinus rhythm with occasional 
premature ventricular complexes, low voltage QRS and 
Q waves in leads V2-3. Neurologic examinations revealed 
no abnormality. Diffusion-weighted magnetic resonance 
imaging (MRI) 6 hours after the onset showed a high 
signal lesion in the right basal ganglia and corona 
radiata. MR angiography (MRA) showed near total 
occlusion (or severe stenosis) of the distal M1 and 
proximal M2 portion of the right middle cerebral artery 
(MCA) (Fig. 2). On the sixth hospital day, follow-up 
MRI and MRA revealed no interval changes. TTE 
showed thickened LV wall with granular sparkling and 
both atrial filling pressure (ejection fraction=28%). 
These findings were compatible with cardiac 
amyloidosis and aggravated LV dysfunction compared to 
previous study three months before. There was mild 
spontaneous echo contrast (SEC) without thrombi on 
transesophageal echocardiography (TEE). The patient 
was treated with heparin and later with warfarin. She 
remained asymptomatic.
Patient 2
A 73-year-old woman suddenly developed global 
aphasia, right hemiplegia and visual disturbances. She 
had hypertension and had been treated with medications 
during the last 5 years. The patient had first been seen 
at our hospital one year earlier because of dyspnea on 
exertion. ECG revealed ST elevation in leads V2-3 and 
inverted T waves in leads V2-5. Echocardiography 
showed concentric left ventricular hypertrophy (LVH) 
with increased LVEDP.
Two months before admission, the patient visited our 
hospital because of pretibial pitting edema. Laboratory 
test results were consistent with a nephrotic syndrome. 
(proteinuria; 4.2 g/day, hypoalbuminemia; 2.7 g/dL, 
hypercholesterolemia; 294 mg/dL) Serum protein 
electrophoresis showed an abnormal zone of restriction 
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Figure 4. T2-weighted MRI of patient 2 shows cerebral infarcts 
in the right PCA and left MCA (arrow) territories.
Figure 5. Echocardiographic findings of patient 2. Left ventri-
cular wall is symmetrically thickened (arrows), and the size of 
the left ventricular cavity is small. Also observed are thickened 
interventricular septum, enlarged left atria and slightly increased
myocardial echogenecity.
in the gamma region, identified as an IgG M component 
with lambda light-chain restriction on immunofixation. 
Urine protein electrophoresis revealed an abnormal zone 
of restriction in the gamma region, identified as Bence- 
Jones protein and IgG lambda M component, 
respectively, on immunofixation. Kidney biopsy, stained 
with Congo red, demonstrated amyloid deposition and 
apple-green birefrigence with polarized light (Fig. 3). 
Bone marrow biopsy of the left iliac crest showed 
moderate plasmocytosis (6.2%). Skeletal survey showed 
diffuse osteopenia of the bony structures, but no lytic 
foci on the skull. Base on these findings, a diagnosis of 
multiple myeloma with amyloidosis was made.
2 Further 
history taking revealed that there was no family history 
of amyloidosis. Thalidomide and dexamethasone was 
prescribed.
The patient had never smoked and did not drink 
alcohol. On examination, cardiac murmur and cervical 
bruit were not heard. Radiographs of the chest showed 
cardiomegaly with pulmonary congestion. ECG revealed 
a sinus rhythm with multiple atrial premature complexes. 
On neurologic examination, she was alert. Her eye balls 
were deviated to the left. There were global aphasia, 
right hemiparesis (I/V), right facial paresis and left 
homonymous hemianopia. Brain computed tomography 
(CT) 2 hours after the onset showed a low density lesion 
in the right posterior cerebral artery (PCA) territory, but 
no evidence of early ischemic change in the left MCA 
territory. Brain CT angiography showed missing of some 
of the left MCA cortical branches, suggesting distal 
MCA occlusion. After the intravenous infusion of tPA 
(0.6 mg/kg), transfemoral cerebral angiography showed 
the recanalization of most of the left MCA branches 
except for an occlusion of one of the frontal branches, 
probably due to emboli migration.
On the fifth hospital day, follow-up MRI revealed 
acute infarcts in the right PCA and left MCA territories 
(Fig. 4). MRA showed no abnormality of intracranial 
arteries, suggesting complete recanalization of the vessel. 
TTE showed symmetrical thickening of the LV wall 
with high LVEDP and IVC plethora that reflected the 
high pressure of the right atrium (ejection fraction= 
50%). Both atria were enlarged and transmitral doppler 
flow revealed typical restrictive pattern. These findings 
were consistent with restrictive cardiomyopathy, and the 
cardiac involvement of amyloidosis was strongly 
suspected (Fig. 5). There were left atrial appendage 
thrombi (17*16 mm) with vigorous biatrial SEC on 
TEE. Cardiac biopsy was not performed because this 
procedure was considered too invasive for her condition. 
Motor nerve studies revealed low amplitude of 
compound muscle action potentials in left ulnar and left 
peroneal nerves and normal velocity in all tested motor 
nerves. Sensory nerve action potentials could not be 
detected in the legs. These findings were consistent with 
the presence of a sensory dominant polyneuropathy.
The patient was treated with low molecular weight 
heparin and later with warfarin. Her neurological 
condition improved and there were mild mixed aphasia Cho KH, et al. Embolic Infarction Associated with Cardiac Amyloidosis 
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and no hemiparesis at one week after the onset. One 
month later, she did not have any neurological deficits.
DISCUSSION
Patient 2 had cerebral infarcts in the territories of 
right PCA and left MCA. There was an early MCA 
recanalization and no remarkable atherosclerotic changes 
in MRA. Patient 1 had a cerebral infarct in the right 
basal ganglia and corona radiata, and near total 
occlusion of the MCA. Although there was no MCA 
recanalization, this young lady had neither vascular risk 
factors nor remarkable atherosclerotic changes in MRA. 
These findings suggest that cardiac embolization was the 
etiology of their stroke. In Patient 1, cardiac amyloidosis 
was diagnosed by the biopsy of cardiac muscles. In 
Patient 2, the diagnosis was supported by characteristic 
echocardiographic findings and amyloid deposits in the 
kidney.
The echocardiographicy findings in our patients 
included symmetrical thickening of the left ventricle wall 
with high LVEDP and IVC plethora. Both atria were 
enlarged and transmitral doppler flow revealed severe 
restrictive pattern. Although characteristic diffuse 
hyperrefractile “granular sparkling” appearance.
3,4 was 
not observed in Patient 2, these findings are consistent 
with restrictive cardiomyopathy secondary to cardiac 
amyloidosis. Because Patient 2 had hypertension, one 
may argue that the cardiomyopathy was caused by long 
standing hypertension. However, this is highly unlikely. 
First, ECG demonstrated low voltage signals, despite 
increased thickness of LV walls on TTE. Second, typical 
restrictive pattern of mitral inflow suggested high 
LVEDP. Third, high right atrial pressure was associated 
with IVC plethora, which was not consistent with 
hypertensive cardiomyopathy. Moreover, the rapid 
progression of the echocardiographic findings one year 
after the first examination (LV posterior wall thickening, 
17 mm vs. 14 mm; interventricular septum thickening, 
17 mm vs. 14 mm; left atrial size, 48 mm vs. 41 mm; 
increased myocardial echogenecity for one year) was not 
consistent with usual hypertensive cardiomyopathy, 
either.
Other causes of restrictive cardiomyopathies such as 
sarcoidosis, endomyocardial fibrosis, radiation, toxin
5 
were ruled out by the history, physical examination and 
laboratory findings. Therefore, it is highly likely that 
Patient 2 had cardiac involvement of amyloidosis. 
Although definitive diagnosis should be based on biopsy 
findings, this invasive procedure was not performed in 
Patient 2 who developed acute stroke. On the other 
hand, Patient 1 was diagnosed as having cardiac 
amyloidosis by myocardial biopsy.
The mechanisms of embolization in amyloid cardio-
myopathy are multifactorial. First, mural thrombosis may 
develop due to blood stasis and intracavitary turbulence. 
Deposition of amyloid fibrils results in reduced 
ventricular compliance with impairment of relaxation 
and eventually contraction.
6-8 Second, amyloid may 
infiltrate into the intima of coronary arteries, which may 
cause myocardial ischemia, endocardial damage, mural 
thrombosis and subsequent cerebral embolism.
6 Third, 
arrhythmia may develop in these patients. Atrial 
fibrillation occurs in about 20% of amyloid cardio-
myopathy due probably to left atrial dilatation and 
failure with increased wall stress.
9,10 The most likely 
mechanism for embolization in Patient 2 was the first 
one, since she had mural thrombus without evidence of 
myocardial ischemia or atrial fibrillation. In Patient 1, 
neither thrombi nor atrial fibrillation was observed. She 
did not belong to one of the above.
Although only SEC was observed on TEE of Patient 
1, prophylactic anticoagulation was administered because 
of the severe LV dysfunction and global LV hypokinesia. 
In Patient 2, anticoagulation was administered because 
left atrial appendage thrombi were observed on TEE. 
However, anticoagulants should be used cautiously in 
these patients as systemic amyloidosis may be associated 
with coagulation abnormalities predisposing to 
bleeding.
5,12 Although Patient 1 remained asympto-
matic, and Patient 2 improved after thrombolysis and 
anticoagluation, the ultimate prognosis of these patients 
is considered poor. According to previous literatures, 
symptomatic heart involvement is the most powerful 
prognostic factor, associated with a median survival of 
only 6 months.
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